We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$53.6B
AUM Growth
+$2.66B
(+5.2%)
Cap. Flow
+$86.8M
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
37.17%
Holding
821
New
56
Increased
227
Reduced
258
Closed
253
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$86.2M |
| 2 |
Alcon
ALC
|
+$81.8M |
| 3 |
NVIDIA
NVDA
|
+$76M |
| 4 |
Corning
GLW
|
+$50.4M |
| 5 |
UnitedHealth
UNH
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$67.4M |
| 2 |
Factset
FDS
|
+$62M |
| 3 |
Euronet Worldwide
EEFT
|
+$42.3M |
| 4 |
Bank of America Series L
BAC.PRL
|
+$39.5M |
| 5 |
OPLN
Openlane
OPLN
|
+$31.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 17.74% |
| 3 | Financials | 11.65% |
| 4 | Healthcare | 11.2% |
| 5 | Communication Services | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SIVB
276
DELISTED
SVB Financial Group
SIVB
| $12.5M | 0.02% |
55,833
-2,842
| -5% | -$657K |
|
277
Texas Roadhouse
TXRH
$13.7B
| $12.4M | 0.02% |
230,692
-13,985
| -6% | -$786K |
|
278
Varex Imaging
VREX
$523M
| $12.3M | 0.02% |
402,540
-55,107
| -12% | -$1.68M |
|
|
RAVN
279
DELISTED
Raven Industries Inc
RAVN
| $12.3M | 0.02% |
342,851
-8,263
| -2% | -$303K |
|
|
AIMC
280
DELISTED
Altra Industrial Motion Corp
AIMC
| $12.3M | 0.02% |
342,729
-300,120
| -47% | -$10.4M |
|
281
Ryman Hospitality Properties
RHP
$7.63B
| $12.3M | 0.02% |
151,276
-2,510
| -2% | -$205K |
|
282
Cabot Corp
CBT
$4.52B
| $12.2M | 0.02% |
256,502
-6,261
| -2% | -$282K |
|
|
VSM
283
DELISTED
Versum Materials, Inc.
VSM
| $12.1M | 0.02% |
234,816
-225,632
| -49% | -$11.6M |
|
284
Pinnacle Financial Partners Inc
PNFP
$15.8B
| $11.9M | 0.02% |
207,557
-17,823
| -8% | -$1M |
|
285
Ameris Bancorp
ABCB
$5.89B
| $11.9M | 0.02% |
302,435
+44,754
| +17% | +$1.63M |
|
|
CSGS
286
DELISTED
CSG Systems International
CSGS
| $11.8M | 0.02% |
242,540
-6,608
| -3% | -$302K |
|
|
PACW
287
DELISTED
PacWest Bancorp
PACW
| $11.8M | 0.02% |
304,388
-11,086
| -4% | -$429K |
|
288
iShares China Large-Cap ETF
FXI
$4.31B
| $11.7M | 0.02% |
273,399
+1,238
| +0.5% | +$52.9K |
|
289
Lamb Weston
LW
$7.19B
| $11.7M | 0.02% |
184,469
+59,876
| +48% | +$3.95M |
|
290
Ascendis Pharma A/S
ASND
$16.8B
| $11.7M | 0.02% |
101,203
-6,141
| -6% | -$735K |
|
291
Viper Energy
VNOM
$14.7B
| $11.6M | 0.02% |
376,530
+101,145
| +37% | +$3.13M |
|
292
Helios Technologies
HLIO
$2.76B
| $11.6M | 0.02% |
249,995
-15,094
| -6% | -$705K |
|
293
Korn Ferry
KFY
$4.28B
| $11.6M | 0.02% |
288,756
-7,041
| -2% | -$320K |
|
294
Wyndham Hotels & Resorts
WH
$5.48B
| $11.5M | 0.02% |
205,802
-11,076
| -5% | -$606K |
|
295
Teledyne Technologies
TDY
$32B
| $11.4M | 0.02% |
41,771
-24,186
| -37% | -$6.03M |
|
|
PRSP
296
DELISTED
Perspecta Inc. Common Stock
PRSP
| $11.3M | 0.02% |
482,853
-231,971
| -32% | -$5.21M |
|
297
OceanFirst Financial
OCFC
$1.91B
| $11.3M | 0.02% |
454,066
-15,758
| -3% | -$387K |
|
298
AdvanSix
ASIX
$444M
| $11.2M | 0.02% |
460,117
-20,782
| -4% | -$583K |
|
299
Marvell Technology
MRVL
$196B
| $11.2M | 0.02% |
470,891
-123,254
| -21% | -$2.88M |
|
|
ACC
300
DELISTED
American Campus Communities, Inc.
ACC
| $11.2M | 0.02% |
243,112
-6,196
| -2% | -$291K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2019 Portfolio in Review
As of Q2 2019, Loomis, Sayles & Company held 821 positions worth $53.6B, up 5.2% from $50.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Loomis, Sayles & Company's Q2 2019 filing shows 56 new, 227 increased, 258 reduced and 253 closed positions. Its largest new stake was Alcon: 1,393,674 shares worth $86.5M. The largest sale was Novartis, an estimated $67.4M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q2 2019 buy was Alcon: 1,393,674 shares worth $86.5M.
- Loomis, Sayles & Company added most to Bristol-Myers Squibb in Q2 2019, an estimated $86.2M increase.
- Loomis, Sayles & Company's biggest Q2 2019 reduction was Novartis, cutting an estimated $67.4M.
- Loomis, Sayles & Company fully exited RingCentral in Q2 2019, selling an estimated $30.4M.
- Loomis, Sayles & Company's ten largest holdings make up 37% of its $53.6B portfolio in Q2 2019.
- Loomis, Sayles & Company opened 56 new positions and closed 253 in Q2 2019.
- Loomis, Sayles & Company's portfolio value rose 5.2% quarter-over-quarter to $53.6B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.